Royal Bank of Canada’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88K | Sell |
|
|||||
|
2025
Q1 | $148K | Sell |
|
|||||
|
2024
Q4 | $1.4M | Sell |
|
|||||
|
2024
Q3 | $2.31M | Sell |
|
|||||
|
2024
Q2 | $2.86M | Buy |
|
|||||
|
2024
Q1 | $3.04M | Sell |
|
|||||
|
2023
Q4 | $4.83M | Buy |
|
|||||
|
2023
Q3 | $3.45M | Buy |
|
|||||
|
2023
Q2 | $3.17M | Sell |
|
|||||
|
2023
Q1 | $2.93M | Sell |
|
|||||
|
2022
Q4 | $3.48M | Buy |
|
|||||
|
2022
Q3 | $2.03M | Buy |
|
|||||
|
2022
Q2 | $2.03M | Buy |
|
|||||
|
2022
Q1 | $1.75M | Sell |
|
|||||
|
2021
Q4 | $2.36M | Buy |
|
|||||
|
2021
Q3 | $1.51M | Buy |
|
|||||
|
2021
Q2 | $1.41M | Buy |
|
|||||
|
2021
Q1 | $1.37M | Buy |
|
|||||
|
2020
Q4 | $642K | Buy |
|
|||||
|
2020
Q3 | $341K | Buy |
|
|||||
|
2020
Q2 | $190K | Sell |
|
|||||
|
2020
Q1 | $295K | Sell |
|
|||||
|
2019
Q4 | $1.25M | Sell |
|
|||||
|
2019
Q3 | $1.03M | Buy |
|
|||||
|
2019
Q2 | $1.54M | Sell |
|
|||||
|
2019
Q1 | $1.77M | Sell |
|
|||||
|
2018
Q4 | $4.92M | Buy |
|
|||||
|
2018
Q3 | $5.31M | Buy |
|
|||||
|
2018
Q2 | $5.13M | Buy |
|
|||||
|
2018
Q1 | $4.8M | Sell |
|
|||||
|
2017
Q4 | $6.78M | Sell |
|
|||||
|
2017
Q3 | $7.37M | Sell |
|
|||||
|
2017
Q2 | $9.33M | Buy |
|
|||||
|
2017
Q1 | $6.61M | Buy |
|
|||||
|
2016
Q4 | $57K | Buy |
|
|||||
|
2016
Q3 | $23K | Buy |
|
|||||
|
2016
Q2 | $1K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $47K | Sell |
|
|||||
|
2015
Q2 | $696K | Buy |
|
|||||
|
2015
Q1 | $13K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $1K | Buy |
|